The
US Centers for Disease Control and Prevention said this week it had
designated a coronavirus variant first seen in India as a "variant of
interest," adding it to the growing collection of viral variants it's
keeping an eye on.
Vaccine
makers are so worried about the chance new variants will escape the
protection offered by immunization that they are already testing booster
shots and tweaking their vaccine formulas to specifically target some
of the more troubling variants.
And
doctors around the world are warning that even more variants will arise
as the virus continues to evolve inside the bodies of the tens of
millions of people it is infecting.
The Curious Case of Geert Vanden Bossche. by Rosemary Frei, MSc RosemaryFrei.ca. On March 6, an open letter by Geert Vanden Bossche,
PhD, DVM, and a video interview of him by Phillip McMillan, MD, from a
company called Vejon Health, were posted online. On the surface, Vanden Bossche appears to perhaps be addressing credible concerns about Covid.
https://banned.video/watch?id=60963a001c422219d9d37710
Vanden Bossche, Geert/ Curriculum Vitae
Personal
Name : Geert Vanden Bossche
Residence: Ottenburg (Huldenberg), Belgium
Nationality: Belgian/US resident and green card holder (granted since 13/7/2010
based on ‘advanced degrees and exceptional abilities’)
Languages: Native Dutch, fluent English, French & German
Education and Professional Training
1977-1980 UNIVERSITY OF NAMUR (FNDP), BE
Faculty of Veterinary Medicine (cum laude)
1980-1983 UNIVERSITY OF GHENT (RUG), BE
Graduated in Veterinary Medicine (cum laude)
Doctoral Script (DVM): “Synthesis and Characterization of Monoclonal
Antibodies against Bovine Rotavirus”
1996 UNIVERSITY OF HOHENHEIM/ STUTTGART, Germany
Habilitation & venia legendi in Virology, Faculty of Agricultural Sciences
Ph.D. Thesis: “Colloidal Aspects of Enteroviral Infectivity in Aqueous
Environments” (i.e., exploring correlates between surfactant-triggered
changes in surface properties of viral particles and their infectious
behavior)